Pfizer (PFE) Q4 earnings report 2023
Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at …
Seagen Inc
Cramer names biopharma companies as industry mergers start to accrue
CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the last few months. He told investors to keep …
Why investors should only trade a name like Linde on fundamentals
Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. U.S. stocks were slightly …
Pfizer 2024 revenue, profit forecast disappoints
Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it sees weak demand for its once-blockbuster Covid products. Pfizer also raised …
Here’s why our favorite way to invest in the clean energy transition jumped out of nowhere
Every weekday the CNBC Investing Club with Jim Cramer releases the Homestretch audio feature in time for the last hour of trading on Wall Street. Here’s today’s edition. There is …
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen
Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie announced plans …
Pfizer (PFE) Q3 earnings report 2023
CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for …
What it means for other pharma deals
Robert Galbraith | Reuters The Federal Trade Commission last week allowed Amgen to move forward with its $27.8 billion acquisition of Horizon Therapeutics under a settlement agreement – a move …